Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus
BV data is critical for the precise interpretation of serial biomarker level changes in T2DM patients. It is deemed reasonable to use RCVs for four bone metabolism markers and five thyroid biomarkers, derived from a healthy population, as a reference for monitoring T2DM patients.
Authors
- Xijie Yu (ORCID: https://orcid.org/0000-0002-3504-7664)
- Yujue Li (ORCID: https://orcid.org/0000-0003-2290-5807)
- Xia Wang (ORCID: https://orcid.org/0000-0002-6986-0979)
- Mei Zhang (ORCID: https://orcid.org/0000-0002-1538-2676)
- Chuan Li (ORCID: https://orcid.org/0000-0002-1482-9480)
- He He (ORCID: https://orcid.org/0000-0002-1513-3987)
- Hengjian Huang (ORCID: https://orcid.org/0000-0003-3030-1552)
- Zhi Liu (ORCID: https://orcid.org/0000-0002-9690-3233)
Institutions
- University of Electronic Science and Technology of China (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-05-20
- DOI
- https://doi.org/10.3389/fendo.2025.1506664
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sichuan University
- West China Hospital, Sichuan University